BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37479616)

  • 1. Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial.
    Orami T; Aho C; Ford RL; Pomat WS; Greenhill A; Kirkham LA; Masiria G; Nivio B; Britton KJ; Jacoby P; Richmond PC; van den Biggelaar AHJ; Lehmann D
    Vaccine; 2023 Aug; 41(37):5392-5399. PubMed ID: 37479616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.
    Wouters I; Desmet S; Van Heirstraeten L; Blaizot S; Verhaegen J; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2019 Feb; 37(8):1080-1086. PubMed ID: 30665775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants.
    Pomat WS; van den Biggelaar AHJ; Wana S; Francis JP; Solomon V; Greenhill AR; Ford R; Orami T; Passey M; Jacoby P; Kirkham LA; Lehmann D; Richmond PC;
    Clin Infect Dis; 2019 Apr; 68(9):1472-1481. PubMed ID: 30184183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.
    Wouters I; Desmet S; Van Heirstraeten L; Herzog SA; Beutels P; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Euro Surveill; 2020 Feb; 25(5):. PubMed ID: 32046817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
    Hadjipanayis A; Efstathiou E; Alexandrou M; Panayiotou L; Zachariadou C; Petrou P; Papaevangelou V
    PLoS One; 2016; 11(10):e0163269. PubMed ID: 27706247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants.
    Britton KJ; Pickering JL; Pomat WS; de Gier C; Nation ML; Pell CL; Granland CM; Solomon V; Ford RL; Greenhill A; Hinds J; Moore HC; Richmond PC; Blyth CC; Lehmann D; Satzke C; Kirkham LS;
    Vaccine; 2021 Sep; 39(38):5401-5409. PubMed ID: 34384633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia.
    Sime WT; Aseffa A; Woldeamanuel Y; Brovall S; Morfeldt E; Henriques-Normark B
    BMC Infect Dis; 2019 May; 19(1):409. PubMed ID: 31077141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.
    Tin Tin Htar M; van Den Biggelaar AHJ; Sings H; Ferreira G; Moffatt M; Hall-Murray C; Verstraeten T; Gessner BD; Schmitt HJ; Jodar L
    Expert Rev Vaccines; 2019 Oct; 18(10):1069-1089. PubMed ID: 31585049
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A; Karabağ-Yılmaz E; Kepenekli E; Karaaslan A; Cagan E; Atıcı S; Atınkanat-Gelmez G; Boran P; Merdan S; Hasdemir U; Söyletir G; Bakır M
    Vaccine; 2016 Jul; 34(33):3894-900. PubMed ID: 27269059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
    Milucky J; Carvalho MG; Rouphael N; Bennett NM; Talbot HK; Harrison LH; Farley MM; Walston J; Pimenta F; Lessa FC;
    Vaccine; 2019 Feb; 37(8):1094-1100. PubMed ID: 30685247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Desmet S; Wouters I; Heirstraeten LV; Beutels P; Van Damme P; Malhotra-Kumar S; Maes P; Verhaegen J; Peetermans WE; Lagrou K; Theeten H
    Vaccine; 2021 Jan; 39(2):372-379. PubMed ID: 33308889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru.
    Gonzales BE; Mercado EH; Castillo-Tokumori F; Montero AE; Luna-Muschi A; Marcelo-Ragas M; Campos F; Chaparro E; Del Águila O; Castillo ME; Saenz A; Reyes I; Hernandez R; Ochoa TJ
    Vaccine; 2023 Jun; 41(28):4106-4113. PubMed ID: 37270366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.
    Rahman T; de Gier C; Orami T; Seppanen EJ; Granland CM; Francis JP; Michael A; Yoannes M; Corscadden KJ; Ford RL; Martinovich KM; Jacoby P; van den Biggelaar AHJ; Lehmann D; Richmond PC; Pomat WS; Thornton RB; Kirkham LS
    Vaccine; 2021 Jun; 39(26):3486-3492. PubMed ID: 34024658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil.
    Fortuna LBDP; Miranda FM; Antunes IMF; Silva AB; Cabral AS; Dolores ÍM; Cardoso-Marques NT; Teixeira LM; Neves FPG
    Vaccine; 2023 May; 41(19):3111-3118. PubMed ID: 37061371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of antibiotic-resistant non-vaccine serotype pneumococci in nasopharyngeal carriage in children after the use of extended-valency pneumococcal conjugate vaccines in Korea.
    Choe YJ; Lee HJ; Lee H; Oh CE; Cho EY; Choi JH; Kang HM; Yoon IA; Jung HJ; Choi EH
    Vaccine; 2016 Sep; 34(40):4771-6. PubMed ID: 27546875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal Carriage Among Indigenous Kichwa Children From the Ecuadorian Andes After the 10-Valent Pneumococcal Vaccine Introduction.
    Regalado L D; Rivera-Olivero IA; Garcia-Bereguiain MA; Tana L; Hernandez I; Zurita J; Vidal JE; Terán E; de Waard JH
    Pediatr Infect Dis J; 2021 Nov; 40(11):e427-e433. PubMed ID: 34609109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
    Temple B; Toan NT; Dai VTT; Bright K; Licciardi PV; Marimla RA; Nguyen CD; Uyen DY; Balloch A; Huu TN; Mulholland EK
    Lancet Infect Dis; 2019 May; 19(5):497-509. PubMed ID: 30975525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece.
    Grivea IN; Priftis KN; Giotas A; Kotzia D; Tsantouli AG; Douros K; Michoula AN; Syrogiannopoulos GA
    Vaccine; 2014 Nov; 32(48):6513-20. PubMed ID: 25252194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotypes and antimicrobial resistance of
    León ME; Samudio M; Kawabata A; Nagai M; Rojas L; Zárate N; Irala J; Leguizamón M; Gómez G; Ortellado J; Blasco R; Franco R; Chamorro G
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37289483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.